WHO advises against remdesivir for Covid-19 treatment

accreditation
0:00
play article
Subscribers can listen to this article

A World Health Organization panel has advised against the use of antiviral drug remdesivir for patients hospitalised with Covid-19 - no matter how ill they are.

Currently, there is no evidence that it improves patient survival or need for ventilation, the panel says.

We live in a world where facts and fiction get blurred
In times of uncertainty you need journalism you can trust. For only R75 per month, you have access to a world of in-depth analyses, investigative journalism, top opinions and a range of features. Journalism strengthens democracy. Invest in the future today.
Subscribe to News24
Voting Booth
Have you entered our Health of the Nation survey?
Please select an option Oops! Something went wrong, please try again later.
Results
Yes
29% - 9758 votes
No
71% - 24104 votes
Vote